Element Capital Management LLC Biogen Inc. Transaction History

Element Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $2.27 Million - $3.13 Million	-10,305 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $1.83 Million - $2.05 Million	8,398 Added 440.38%	10,305 $2.4 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $906,544 - $999,270	-4,134 Reduced 68.43%	1,907 $446,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $4.04 Million - $6.32 Million	-18,636 Reduced 75.52%	6,041 $1.43 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $2.36 Million - $2.99 Million	8,481 Added 52.36%	24,677 $7.43 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $2.04 Million - $2.66 Million	6,937 Added 74.92%	16,196 $5.72 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $2.38 Million - $2.84 Million	9,259 New	9,259 $2.69 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.